- Recurrent venous thromboembolism2011 | First Faculty of Medicine
- Unknown cause of the onset and the recurrency of venous thromboembolism2006 | First Faculty of Medicine
- Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolismPublication without faculty affiliation
- Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study2017 | Third Faculty of Medicine
- EINSTEIN-PE study - rivaroxaban in the treatment of pulmonary embolism2012 | Second Faculty of Medicine
- Extended prophylaxis of venous thromboembolism with idraparinux2007 | First Faculty of Medicine
- AMPLIFY-EXT study. Apixaban in the treatment of venous thromboembolism2013 | First Faculty of Medicine
- Patient with thrombohemorrhagic risk - choice of anticoagulation2020 | Faculty of Medicine in Pilsen
- Subsegmental pulmonary embolism - diagnosis and clinical significance2021 | Publication without faculty affiliation
- Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study2012 | Publication without faculty affiliation
- Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort studyPublication without faculty affiliation
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism2012 | Second Faculty of Medicine
- Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study2008 | Second Faculty of Medicine
- Systolic blood pressure and mortality in acute symptomatic pulmonary embolismPublication without faculty affiliation
- Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism2013 | Second Faculty of Medicine